LumiraDx Ltd (LMDX) Stock
LMDX is no longer traded. LumiraDx was delisted from the Nasdaq in March 2024.
Prices on this page are historical; the last trade was March 11, 2024 at $0.02.
LumiraDx stock price history
LMDX final trading statistics
- Final close
- $0.02
- Final trading day
- Mar 11, 2024
- Market cap at delisting
- $249.63M
- Shares outstanding
- 161.02M
- Final 52-week range
- $0.01 – $1.03
- Avg. volume (final 3 mo.)
- 11,955,135
- All-time high (split-adj.)
- $10.49 · Nov 2021
- All-time low (split-adj.)
- $0.01 · Feb 2024
- Return since IPO
- -99.8%
- Beta
- 1.71
- Book value / share
- -$0.67
- Price / book
- -0.02
LumiraDx annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2022 | $254.48M | -$449.2M | -$1.59 |
| FY2021 | $421.43M | -$100.8M | -$0.35 |
| FY2020 | $139.15M | -$241.0M | -$2.79 |
| FY2019 | $23.14M | -$133.1M | -$1.85 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About LumiraDx Ltd
LumiraDx Limited operates as a point of care diagnostics company. The company focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. It manufactures and commercializes a diagnostic platform that supports various tests with lab comparable performance at the point of care. The company has tests on the market and in development covering infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders, as well as a portfolio of COVID-19 testing solutions. Its diagnostic testing solutions are deployed by governments and healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools, and workplaces to screen, diagnose, and monitor wellness, as well as disease. The company is headquartered in London, the United Kingdom.
LumiraDx stock FAQ
What happened to LumiraDx stock?
LumiraDx stock was delisted from the Nasdaq. Its final close was $0.02 on March 11, 2024.
Is LMDX stock still trading?
No. LMDX was delisted from the Nasdaq in March 2024 and no longer trades on a U.S. exchange.
What was the last price of LMDX stock?
LMDX closed at $0.02 on its final trading day, March 11, 2024, for a market value of about $249.63M.
What were LumiraDx's revenue and earnings in its last full fiscal year?
LumiraDx reported revenue of $254.48M and net income of -$449.2M in fiscal 2022, its last full year as a public company.
When did LumiraDx go public?
LumiraDx Ltd stock began trading on September 28, 2021.